A. Fernandez et al., NEUROTENSIN, SUBSTANCE-P, DELTA-OPIOID AND MU-OPIOID RECEPTORS ARE DECREASED BASAL GANGLIA OF PARKINSONS-DISEASE PATIENTS, Neuroscience, 61(1), 1994, pp. 73-79
The specific binding of [H-3]neurotensin, [H-3]substance P, [H-3]D-Ala
(2)-D-Leu(5)-enkephalin (delta receptors) and [H-3]-Tyr-D-Ala-Gly-(NMe
)Phe-Gly-ol (mu receptors) were studied in membrane preparations of ca
udate nucleus, putamen, globus pallidus and substantia nigra from pati
ents with Parkinson's disease and from age-matched controls. The densi
ty of neurotensin receptors was decreased in globus pallidus (lateral
and medial segments) in parkinsonian brain. Substance P receptors were
reduced in the putamen (anterior and posterior) and in lateral globus
pallidus in Parkinson's disease. There was a reduction in the density
of opioid receptors in posterior putamen and in mu receptors in cauda
te nucleus and putamen (anterior and posterior). No differences in neu
ropeptide receptor binding were observed in substantia nigra from park
insonian brains compared with control subjects. The reductions in neur
opeptide receptor density were less marked than the decrease in caudat
e and putamen content of dopamine and its metabolites. This suggests t
hat neuropeptide receptors are only partially localized to striatal do
pamine terminals.